Edward S. Kim, MD
Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC
Edward S. Kim, MD is Chair of Solid Tumor Oncology and Investigational Therapeutics and the Donald S. Kim Distinguished Chair for Cancer Research at the Levine Cancer Institute, Carolinas HealthCare System in Charlotte, NC.
Dr. Kim has recently moved from The University of Texas MD Anderson Cancer Center in Houston, Texas where he was an Associate Professor of medicine, Chief of the Section of Head and Neck Medical Oncology and Director of Clinical Research Operations in the Department of Thoracic/Head and Neck Medical Oncology.
Dr Kim received his Bachelor of Science and medical degrees from the Honors Program in Medical Education (HPME) at Northwestern University in Chicago, Illinois, 1996. Dr Kim completed an internship and residency in internal medicine at the Baylor College of Medicine in Houston, Texas, 1996-1999, and his fellowship in medical oncology at The University of Texas MD Anderson Cancer Center, 1999-2001.
Dr Kim studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck, as well as thymic cancers. He serves as principal investigator on numerous clinical studies including the Department of Defense Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) or personalized medicine program in lung cancer. Dr Kim studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck, as well as thymic cancers.
Dr Kim serves on the editorial boards of Journal of Clinical Oncology, Clinical Cancer Research, and Clinical Lung Cancer and is a member of numerous associations and societies, including ASCO, AACR, SWOG, IASLC and the Texas Medical Society. Dr Kim is also the recipient of several awards including the ASCO Young Investigators Award and the AACR Scholar in Training Award. He also served as the principal investigator of the MD Anderson SWOG U10 institutional grant and is the recipient of a V Foundation Grant.
Dr Kim is the author or coauthor of more than 100 published articles, book chapters, reviews in journals such as Lancet, Journal of Clinical Oncology, Cancer Discovery, Cancer, and Cancer Prevention Research, involving cancer therapeutics and prevention with chemotherapy and novel targeted agents, with particular emphases on lung cancer and head and neck cancer.